Key result
Gallbladder angiosarcoma is a rare malignancy primarily treated with surgery, with 5 out of 8 reported cases resulting in death during a mean follow-up of 10 months.
Why the study?
Angiosarcoma of the gallbladder is a rare diagnostic entity that is rarely encountered by pathologists and infrequently reported in the literature.
Gallbladder angiosarcoma is an extremely rare malignancy with poor prognosis, typically presenting with abdominal pain and mass, and diagnosed via histopathology and immunohistochemistry.
Answers are grounded in this paper and cite their sources.
Data on gallbladder angiosarcoma remain limited to case reports; leaves open standardized diagnostic and therapeutic approaches.
BACKGROUND: Angiosarcoma of the gallbladder is a rare diagnostic entity rarely encountered by pathologists and has rarely been reported in literature. This review aimed to examine the clinicopathological features, immunohistochemistry, treatment, and outcomes of gallbladder angiosarcoma. METHODS: A search of the PubMed, Science Direct and Google Scholar was done with the search terms ("angiosarcoma" OR "angiosarcomas") AND ("gallbladder" OR "gallbladders"). Based on inclusion and exclusion criteria, only case reports could be used for this review. RESULT: 8 case reports were chosen in the end for analysis. The mean age of the patients at presentation was 65 years. It was most frequently observed in males. Abdominal pain and palpable mass were the most commonly reported symptoms. Cholelithiasis and anemia were also reported. On histopathology morphologically epithelioid appearance of angiosarcoma was evident. Cytokeratin (CK) AE1/AE3, Von willebrand factor, Factor VIII antigen, Vimentin, CD31 were positive. Meanwhile, UEA, CD34, CD117, S-100, Keratin, EMA, and CEA showed negative outcome. Surgery was the preferred method of treatment and a mean 10-months follow-up was done. CONCLUSION: Despite the unavailability of convincing data, histological and immunohistochemical analyses play a major role in the diagnosis of gallbladder angiosarcoma. Nevertheless, more comprehensive clinical studies are required to provide universal guidelines for the treatment and diagnosis of angiosarcoma of the gallbladder.
No takes yet. Share an insight, caveat, or question.
Salehi et al. (2024) conducted a review in Angiosarcoma of the gallbladder (n=8). Gallbladder angiosarcoma was evaluated on Clinical outcomes and survival. Gallbladder angiosarcoma is a rare malignancy primarily treated with surgery, with 5 out of 8 reported cases resulting in death during a mean follow-up of 10 months.
Synapse has enriched 10 related papers. Consider them for comparative context: